Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The original summary, manufacturer discussion and dialysis advice are not mutually equivalent. Current tuberculosis/dialysis professional guidance must be reviewed separately.
Check source scope before reading a dose
Stanford - pyrazinamide renal schedule
Product / population
Adults; combination TB treatment. Guide page 7.
Renal method
CrCl in mL/min; lean body weight in obesity.
Source revision
Revision date not stated in the reviewed page.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
Stanford Health Care Antimicrobial Safety and Sustainability · Adults; combination TB treatment. Guide page 7.
Renal method: CrCl in mL/min; lean body weight in obesity. Source date: Revision date not stated in the reviewed page. Retrieved: 2026-09-05
Locally included source-specific summary. Regimen differences are not automatically resolved.
Dosing / renal protocol and limits
Usual oral dose is 25 mg/kg daily, maximum 2000 mg/day. At CrCl <30 mL/min, use 25 mg/kg three times weekly. IHD uses that intermittent schedule after dialysis; no CRRT regimen is supplied. Stanford uses lean body weight for obesity.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.